Researchers develop new PET imaging probe to detect inflammation, aiming for human trials.

Researchers at Dana-Farber Cancer Institute have developed a new PET imaging probe, CD45-PET, to detect inflammation by targeting CD45, a marker on immune cells. The probe has shown potential in animal models, correlating well with clinical symptoms and tissue analysis. A human version of the probe has also been developed and tested successfully in humanized mouse models. The team is now aiming for clinical trials, with the goal of using CD45-PET to guide anti-inflammatory treatments and diagnose inflammatory conditions.

2 months ago
5 Articles